BIOINFORMATICS SHARED RESOURCE (BISR) The Bioinformatics Shared Resource (BISR) continues to provide cutting-edge support in bioinformatics and computational biology for basic, translational, and clinical research programs throughout MD Anderson. Its personnel include 15 faculty, 15 statistical analysts, 2 bioanalysts, and 10 software engineers, all associated with the Department of Bioinformatics and Computational Biology (DBCB) led by John Weinstein, MD, PhD. DBCB, a leader in bioinformatics nationally and internationally, provides high-quality academic research, education, and computer science as vital ?infrastructure? for the BISR's support function. The BISR analyzes a comprehensive spectrum of bioinformatic data types, including sequences (whole genome, whole exome, RNA-seq, ChIP-seq, ChiRP-seq; bisulfite-seq, ATAC-seq, etc.); DNA, RNA, and protein microarrays; flow cytometry (fluorescence and CyTOF); mass spectrometry (targeted and discovery for proteomics and metabolomics); siRNA, shRNA; CRISPR/Cas9; histopathological and clinical images including CyTOF images; and marker-driven clinical trial data. In addition, BISR faculty and software engineering teams develop professional-grade, user-friendly visualization and analysis software for use at MD Anderson and worldwide. BISR faculty are currently lead principal investigators on 4 NIH U24 grants and an NIH U01 grant for development, application, and sharing of the software. The BISR is proactive in education, both for the next generation of informatics specialists (through the MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Rice University, and Baylor College of Medicine) and for biologists and clinical researchers who wish to learn elements of data science. Bioinformatics assistance can be requested through 1) the BISR website, 2) weekly walk-in clinics, 3) informal contact, or 4) a DBCB faculty member designated as a liaison for each department or program. As much as possible, BISR analysts and faculty work longitudinally with particular departments and programs to maximize continuity and domain expertise. Over the previous grant cycle, the BISR has supported >900 projects for 355 cancer center members (219 with peer-reviewed funding) in 64 MD Anderson departments, representing all 16 CCSG programs. Included were all 13 MD Anderson Moon Shots plus SPOREs, P01s, and R01s. The most active BISR users were the Head and Neck Cancer (21% total usage), Hematologic Malignancies (15%), and Lung Cancer (11%) CCSG programs. Peer-review funded investigators accounted for 85% of the usage, and 6% ($240,027) of total costs are requested from the CCSG. The BISR has no chargebacks, but users are expected to provide support if their projects are large. BISR faculty averaged 10.3 authorships in 2017, with more than 500 authorships over the 6-year period. BISR staff plus faculty have contributed to 865 papers since the last review: 114 (13%) in journals with IF >20, 273 (32%) in those with IF >10, and 624 (72%) in those with IF >5. The BISR's focus on issues of rigor, reproducibility, accessibility, and interoperability is in tune with FAIR principles and the NIH's new Data Science initiative, in which DBCB is primed to participate.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016672-43
Application #
9794666
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
43
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Hui, David; Hess, Kenneth; Dibaj, Seyedeh S et al. (2018) The minimal clinically important difference of the Richmond Agitation-Sedation Scale in patients with cancer with agitated delirium. Cancer 124:2246-2252
LeBleu, Valerie S; Kalluri, Raghu (2018) A peek into cancer-associated fibroblasts: origins, functions and translational impact. Dis Model Mech 11:
Liu, Yang; Sethi, Nilay S; Hinoue, Toshinori et al. (2018) Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell 33:721-735.e8
Saintigny, Pierre; Mitani, Yoshitsugu; Pytynia, Kristen B et al. (2018) Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy. Cancer 124:3693-3705
Jiang, Xuejie; Mak, Po Yee; Mu, Hong et al. (2018) Disruption of Wnt/?-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in FLT3-Mutant Acute Myeloid Leukemia. Clin Cancer Res 24:2417-2429
Saltz, Joel; Gupta, Rajarsi; Hou, Le et al. (2018) Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images. Cell Rep 23:181-193.e7
Dondossola, Eleonora; Alexander, Stephanie; Holzapfel, Boris M et al. (2018) Intravital microscopy of osteolytic progression and therapy response of cancer lesions in the bone. Sci Transl Med 10:
Yue, Jinbo; Shi, Qiuling; Xu, Ting et al. (2018) Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study. Qual Life Res 27:1563-1570
Allen, Julie K; Armaiz-Pena, Guillermo N; Nagaraja, Archana S et al. (2018) Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction. Cancer Res 78:3233-3242
Nguyen, Tuan M; Kabotyanski, Elena B; Dou, Yongchao et al. (2018) FGFR1-Activated Translation of WNT Pathway Components with Structured 5' UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation Initiation. Cancer Res 78:4229-4240

Showing the most recent 10 out of 12418 publications